Endocrine Health in Childhood Cancer Survivors

Pediatr Clin North Am. 2020 Dec;67(6):1171-1186. doi: 10.1016/j.pcl.2020.08.002.

Abstract

Endocrine late effects, including reproductive disorders and secondary thyroid cancer, have been reported in up to 50 %childhood cancer survivors (CCS) more than 5 years after treatment. Most endocrine disorders are amenable to treatment; awareness of symptoms is therefore of great importance. Recognition of these symptoms may be delayed however because many are nonspecific. Timely treatment of endocrine disorders improves quality of life in CCS and prevents possible consequences, such as short stature, bone and cardiovascular disorders, and depression. At-risk CCS must therefore be regularly and systematically monitored. This article provides a summary of the most commonly reported endocrine late effects in CCS.

Keywords: Bone health; Childhood cancer survivor; Growth hormone deficiency; Hypothyroidism; Late effects; Metabolic syndrome; Radiation effects; Secondary thyroid cancer.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Cancer Survivors*
  • Drug-Related Side Effects and Adverse Reactions
  • Endocrine System / surgery
  • Endocrine System Diseases / etiology*
  • Humans
  • Neoplasms / therapy*
  • Radiotherapy / adverse effects
  • Risk Factors

Substances

  • Antineoplastic Agents